» Articles » PMID: 17439386

The Prevalence, Burden, and Treatment of Urinary Incontinence Among Women in a Managed Care Plan

Overview
Date 2007 Apr 19
PMID 17439386
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Urinary incontinence (UI) symptoms are common among women, yet only a small proportion of women with incontinence receive a diagnosis and treatment. We used survey and utilization data to determine the prevalence, burden, and treatment use for incontinence among women at Kaiser Permanente in Northern California.

Methods: In 2002, we surveyed 6726 female health plan members about health issues, including incontinence. We assessed type and bothersomeness of incontinence symptoms in the previous 7 days. For survey respondents and a 10% sample of female plan members (n = 108,825), we assessed use from 1997 to 2003.

Results: The survey response rate was 49.7% (3344 of 6726); 44% of respondents reported incontinence symptoms in the previous 7 days, with over half of these women reporting that these symptoms bothered them. Fifteen percent of women with incontinence symptoms had a diagnosis consistent with incontinence in the previous 5 years. One third of the women reporting current bothersome incontinence and 14 or more incontinence episodes in the last 7 days had a diagnosis consistent with incontinence in the previous 5 years. Among women who had received medical or surgical treatment for incontinence in the previous 5 years, approximately half currently report being bothered by their symptoms.

Conclusions: Prevalence of bothersome incontinence symptoms among females in a prepaid health plan is high. However, only a small proportion of these women received a diagnosis or treatment for incontinence symptoms in the last 5 years. Efforts to improve the detection and treatment of bothersome incontinence symptoms are needed.

Citing Articles

A randomized controlled pilot trial to assess the effectiveness of a specially formulated food supplement and pelvic floor muscle training in women with stress-predominant urinary incontinence.

Takacs P, Pakozdy K, Koroknai E, Erdodi B, Krasznai Z, Kozma B BMC Womens Health. 2023; 23(1):321.

PMID: 37340306 PMC: 10283266. DOI: 10.1186/s12905-023-02476-z.


Morphological and histological changes in the urethra after intraurethral nonablative erbium YAG laser therapy: an experimental study in beagle dogs.

Xu S, Abulikim K, Wu X, Cheng Y, Ling Q, Rao K Lasers Med Sci. 2022; 37(8):3137-3146.

PMID: 35614283 PMC: 9525421. DOI: 10.1007/s10103-022-03575-3.


An Exercise Training and Healthy Eating Group Program (ATHENA) for Overweight and Obese Women with Urinary Incontinence: An Intervention Description.

Howard Z, Ross L, Smith L, Baker N, Nucifora J, Townsend H Healthcare (Basel). 2020; 8(4).

PMID: 33352909 PMC: 7767144. DOI: 10.3390/healthcare8040575.


Nonbiologic factors that impact management in women with urinary incontinence: review of the literature and findings from a National Institute of Diabetes and Digestive and Kidney Diseases workshop.

Norton J, Dodson J, Newman D, Rogers R, Fairman A, Coons H Int Urogynecol J. 2017; 28(9):1295-1307.

PMID: 28674734 DOI: 10.1007/s00192-017-3400-x.


Knowledge of the Disease, Perceived Social Support, and Cognitive Appraisals in Women with Urinary Incontinence.

Szymona-Palkowska K, Janowski K, Pedrycz A, Mucha D, Ambrozy T, Siermontowski P Biomed Res Int. 2017; 2016:3694792.

PMID: 28097132 PMC: 5209598. DOI: 10.1155/2016/3694792.